Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| 2011/0201673 |
LPL VARIANT THERAPEUTICS The invention provides for the use of a therapeutic derived from a truncated lipoprotein lipase protein (LPL S447X), including nucleic acids encoding such... |
| 2011/0201672 |
SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES The invention relates to specific C-Class semi-soft CpG immunostimulatory oligonucleotides that are useful for stimulating an immune response. In particular the... |
| 2011/0201671 |
Compositions And Methods For Inhibiting Expression Of A Gene From The
Ebola Virus The invention relates to a double-stranded ribonucleic acid (dsRNA) FOR INHIBITING THE expression of a gene from the Ebola virus. |
| 2011/0201670 |
OLIGORIBONUCLEOTIDES AND METHODS OF USE THEREOF FOR TREATMENT OF FIBROTIC
CONDITIONS AND OTHER DISEASES The invention relates to a double-stranded compound, preferably an oligoribonucleotide (siRNA), which down-regulates the expression of a human TGaseII gene at... |
| 2011/0201669 |
METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER The present invention relates to the diagnosis and treatment of cancer, and in particular breast cancer. Specifically, in some embodiments the invention relates... |
| 2011/0201668 |
REGULATION OF NEUROTRANSMITTER RELEASE THROUGH ANION CHANNELS A novel use of anion channels, preferably Ca2+-activated anion channels (CAACs), in regulating release of neurotransmitters from neurons and/or astrocytes is... |
| 2011/0201667 |
COMPOSITIONS AND METHODS FOR SILENCING EBOLA VIRUS GENE EXPRESSION The present invention provides compositions comprising therapeutic nucleic acids (e.g., interfering RNA such as siRNA) that target Ebola virus (EBOV) gene... |
| 2011/0201666 |
COMPOUNDS FROM MYCELIUM OF ANTRODIA CINNAMOMEA AND USE THEREOF The present invention relates to compounds from mycelium of Antrodia cinnamomea. The present invention also relates to a composition and a method for treating... |
| 2011/0201665 |
Compositions, Methods, and Kits for Treating Influenza Viral Infections The present invention provides compositions, methods, and kits for treating or preventing a viral infection (e.g., an infection caused by an influenza virus). |
| 2011/0201664 |
Methods and Compositions for Treatment of Prostate Intraepithelial
Neoplasia Provided herein are methods of treatment of prostate intraepithelial neoplasia (PIN) by administering bexarotene. Also provided are pharmaceutical compositions... |
| 2011/0201663 |
BENZO (F) ISOINDOL-2-YLPHENYL ACETIC ACID DERIVATIVES AS EP4 RECEPTOR
AGONISTS A compound of formula (I) or a pharmaceutically acceptable derivative thereof, ##STR00001## wherein, R.sup.1 R.sup.2 R.sup.3, R.sup.4, R.sup.5, R.sup.6, X and Y... |
| 2011/0201662 |
METHOD FOR PRODUCING XPS MOULDED PIECES PROVIDED WITH INSECTICIDE Process for the production of insecticide-modified extruded polystyrene foam (XPS) preforms, comprising the steps (a) heating polystyrene (PS) until a polymer... |
| 2011/0201661 |
Spiro Derivatives of Parthenin as Novel Anticancer Agents The present invention relates to novel spiro derivatives of parthenin prepared by the dipolar cycloaddition of various dipoles viz, benzonitrile oxides,... |
| 2011/0201660 |
Method for Controlling Plant Disease The combination of ethaboxam and transgenic plants provides enhanced plant protection in controlling plant disease. According to the present invention, an... |
| 2011/0201659 |
AGENT FOR PREVENTING OR TREATING ZOSTER-ASSOCIATED PAIN The present invention relates to a pharmaceutical composition and method for preventing or treating a zoster-associated pain. The inventors found that an... |
| 2011/0201658 |
Pharmaceutical package The present invention relates to a pharmaceutical package including a pharmaceutical preparation containing ... |
| 2011/0201657 |
AMIDE SUBSTITUTED INDAZOLE AND BENZOTRIAZOLE DERIVATIVES AS
POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts or tautomers thereof which are inhibitors of poly (ADP-ribose)... |
| 2011/0201656 |
NOVEL DIPHENYL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF
NICOTINIC ACETYLCHOLINE RECEPTORS This invention relates to novel diphenyl 1,2,3-triazole derivatives, which are found to be modulators of the nicotinic acetylcholine receptors. Due to their... |
| 2011/0201655 |
PHARMACEUTICAL COMPOSITION IMPROVING INTESTINAL ABSORPTION An object of the present invention is to provide a pharmaceutical composition that improves intestinal absorption of a compound having a structure represented... |
| 2011/0201654 |
THERAPEUTIC COMBINATION This invention relates to pharmaceutical combinations of amlodipine or a pharmaceutically acceptable acid addition salt thereof and atorvastatin or a... |
| 2011/0201653 |
METHOD FOR INHIBITING AND/OR PREVENTING FORMATION OF CANCER METASTASES AND
SECONDARY MALIGNANT CANCER The invention relates to a method for inhibiting and/or preventing formation of cancer metastases and secondary malignant cancers by administration to a subject... |
| 2011/0201652 |
2,4-Disubstituted Pyrrolidine Orexin Receptor Antagonists The present invention is directed to 2,4-disubstituted pyrrolidine amide compounds which are antagonists of orexin receptors, and which are useful in the... |
| 2011/0201651 |
MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides... |
| 2011/0201650 |
CYCLOHEXANE DERIVATIVE AND PHARMACEUTICAL USE THEREOF A compound has a strong analgesic action against both nociceptive pain and neuropathic pain and has less side effects, and is medically useful. The compound... |
| 2011/0201649 |
AGRICULTURAL COMPOSITION Provided is an agricultural composition comprising a compound represented by the formula (I) or a salt thereof or a hydrate thereof, for controlling a plant... |
| 2011/0201648 |
POLY-HETEROARYL DERIVATIVES FOR THE TREATMENT OF CANCER The present invention relates to Penta-hexa-, hepta-, octa-, nona- and, deca-heteroaryl derivatives, comprising a combination of heterocycle 1 (Het-1).sub.a... |
| 2011/0201647 |
[4-(5-AMINOMETHYL-2-FLUORO-PHENYL)-PIPERIDIN-1-YL]-[7-FLUORO-1-(2-METHOXY--
... The present invention is directed to an indole benzylamine compound of formula I: ##STR00001## useful as an inhibitor of tryptase. In addition, the present... |
| 2011/0201646 |
OPTICAL ISOMERS OF AN ILOPERIDONE METABOLITE The present invention relates to novel isomers of a metabolite of Iloperidone, their preparation, their use as pharmaceuticals and pharmaceutical compositions... |
| 2011/0201645 |
Method Of Treating Attention Deficit Disorders With D-Threo
Methylphenidate Methods for treating Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, AIDS Dementia Complex and cognitive decline in HIV-AIDS while... |
| 2011/0201644 |
CRYSTALLINE FORM OF A BENZIMIDAZOLE-CARBOXAMIDE MEDICINAL COMPOUND The invention provides crystalline forms of the novel benzimidazole-carboxamide 5-HT.sub.4 receptor agonist compound, ... |
| 2011/0201643 |
NOVEL N-SUBSTITUTED TETRAHYDROISOQUINOLINE/ISOINDOLINE HYDROXAMIC ACID
COMPOUNDS Compounds of a certain formula (I) wherein R1, R2, R3, X, Y, r, s, t, u and v have the meanings as defined in the specification, and the salts, solvates and... |
| 2011/0201642 |
Bioactive Compounds The invention relates to bioactive compounds derived from an endophytic Aspergillus sp. fungus strain isolated from a Malaysian medicinal plant Garcinia... |
| 2011/0201641 |
INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS The compound (+) {7R-[[(4-fluorophenyl)sulfonyl] (methyl)ammo]-6,7,8,9-tetrahydropyrido[1,2-a]mdol-10-yl}acetic acid and pharmaceutically acceptable salts... |
| 2011/0201640 |
TRICYCLIC COMPOUND Provided is a tricyclic compound having a PPAR .gamma. agonist activity, which is represented by the general formula (I) wherein Z represents a single bond or... |
| 2011/0201639 |
STABILIZED TACROLIMUS COMPOSITION The invention relates to a stable pharmaceutical composition comprising comprising a solid dispersion of tacrolimus in a vehicle further comprising a... |
| 2011/0201638 |
PHENANTHROINDOLIZIDINE COMPOUND AND NFkB INHIBITOR CONTAINING SAME AS
ACTIVE INGREDIENT A novel compound having an excellent NF.kappa.B inhibitory effect is provided and specifically disclosed is a compound represented by the following formula (1)... |
| 2011/0201637 |
PHENANTHROINDOLIZIDINE DERIVATIVE AND NFKB INHIBITOR CONTAINING SAME AS
ACTIVE INGREDIENT A novel compound having an excellent NF.kappa.B inhibitory effect is provided. Specifically disclosed is a compound represented by the following formula (1) or... |
| 2011/0201636 |
USE OF 14,15-DIHYDRO-20,21-DINOREBURNAMENIN-14-OL FOR THE TREATMENT AND/OR
PREVENTION OF SERIOUS DEPRESSION AND... The invention relates to a novel therapeutic use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment of serious depression in humans, particularly... |
| 2011/0201635 |
SUBSTITUTED SPIROINDOLINONES There is provided a compound of the formula ##STR00001## wherein X, Y, W, R.sub.1, R.sub.2 and R.sub.3 are as described herein. The compounds have activity as... |
| 2011/0201634 |
DIHYDROPYRIDIMIDINONE COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR
DISEASES AND PROCESS FOR PREPARING THE SAME The present invention relates to a dihydropyrimidinone compound of formula (I) wherein X represents O, S, etc. and R' represents alkyl, alkoxy, thioalkyl,... |
| 2011/0201633 |
ALFUZOSIN TABLETS AND SYNTHESIS A monolithic composition includes alfuzosin in a polymeric matrix adapted to release 13-33% of the alfuzosin within 2 hours, 40-60% of the alfuzosin within 7... |
| 2011/0201632 |
2,5-Disubstituted Piperidine Orexin Rceptor Antagonists The present invention is directed to 2,5-disubstituted piperidine amide compounds which are antagonists of orexin receptors, and which are useful in the... |
| 2011/0201631 |
PHARMACEUTICAL FORMULATIONS COMPRISING PEMETREXED Pharmaceutical formulations comprising amorphous pemetrexed or its salts, and processes to prepare the formulations. |
| 2011/0201630 |
Fused Pyridine Derivatives as Kinase Inhibitors A series of heteroaryl-substituted fused pyridine derivatives, in particular heteroaryl-substituted thieno[3,2-6]pyridine derivatives, being selective... |
| 2011/0201629 |
CYCLOHEXYL AMIDE DERIVATIVES AS CRF RECEPTOR ANTAGONISTS There are described cyclohexyl amide derivatives of Formula I, ##STR00001## which are useful as corticotropin releasing factor (CRF) receptor antagonists and as... |
| 2011/0201628 |
HETEROCYCLIC JAK KINASE INHIBITORS The present invention relates to compounds of Formula (I) and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation.... |
| 2011/0201627 |
FREEZE-DRIED REPARATION OF TETRODOTOXIN AND THE PRODUCING METHOD THEREOF A stable freeze-dried powder preparation of tetrodotoxin and the producing method thereof. The freeze-dried powder preparation has tetrodotoxin as the main... |
| 2011/0201626 |
4,6-DIAMINOPYRIMIDINE STIMULATORS OF SOLUBLE GUANYLATE CYCLASE The present invention relates to new 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase, pharmaceutical compositions thereof, and methods of use... |
| 2011/0201625 |
Organic Comopunds A compound of Formula I ##STR00001## or a hydrate or solvate thereof, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, and... |
| 2011/0201624 |
Pharmaceutical Composition for Prevention and Treatment of Diabetes or
Obesity Comprising a Compound that... The present invention relates to a pharmaceutical composition for the prevention and treatment of diabetes or obesity comprising as active ingredients a... |
Copyright 2008−2013 Patents.com
